BIG Stock Chart & Stats
€2.82
--
At close: 4:00 PM EST
€2.82
--
Day’s Range― - ―
52-Week Range€2.50 - €4.95
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.47K
Market Cap
€5.71M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding2,038,738
10 Day Avg. Volume3,484
30 Day Avg. Volume1,470
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.33
Revenue Forecast (FY)€7.45M
BIG FAQ
What was Bio-Gate AG’s price range in the past 12 months?
Bio-Gate AG lowest stock price was €2.50 and its highest was €4.95 in the past 12 months.
What is Bio-Gate AG’s market cap?
Bio-Gate AG’s market cap is €5.71M.
When is Bio-Gate AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bio-Gate AG’s earnings last quarter?
Currently, no data Available
Is Bio-Gate AG overvalued?
According to Wall Street analysts Bio-Gate AG’s price is currently Overvalued.
Does Bio-Gate AG pay dividends?
Bio-Gate AG does not currently pay dividends.
What is Bio-Gate AG’s EPS estimate?
Bio-Gate AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-Gate AG have?
Bio-Gate AG has 2,038,738 shares outstanding.
What happened to Bio-Gate AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bio-Gate AG?
Currently, no hedge funds are holding shares in DE:BIG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bio-Gate AG Stock Smart Score
Company Description
Bio-Gate AG
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Dermapharm Holding SE
―
PAUL HARTMANN AG
―
B.M.P. Pharma Trading AG
―
HAEMATO AG
―
Novogenia Holding AG
―